Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML

被引：0
|
作者：
Maria Solovey
Ying Wang
Christian Michel
Klaus H. Metzeler
Tobias Herold
Joachim R. Göthert
Volker Ellenrieder
Elisabeth Hessmann
Stefan Gattenlöhner
Andreas Neubauer
Dinko Pavlinic
Vladimir Benes
Oliver Rupp
Andreas Burchert
机构：
[1] Philipps University Marburg,Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Campus Marburg
[2] LMU Munich,Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital
[3] University Hospital Essen,Department of Hematology
[4] University Hospital Goettingen,Department of Gastroenterology
[5] Justus-Liebig-University,Institute of Pathology
[6] EMBL Heidelberg ,Genomics Core Facility
[7] University Giessen,Department of Bioinformatics and Systems Biology
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
FLT3; Acute myeloid leukemia; Hematopoietic stem cells; NFATC1; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] CELL TYPE SPECIFICITY AND ACTIVATION REQUIREMENTS FOR NFAT-1 (NUCLEAR FACTOR OF ACTIVATED T-CELLS) TRANSCRIPTIONAL ACTIVITY DETERMINED BY A NEW METHOD USING TRANSGENIC MICE TO ASSAY TRANSCRIPTIONAL ACTIVITY OF AN INDIVIDUAL NUCLEAR FACTOR
    VERWEIJ, CL
    GUIDOS, C
    CRABTREE, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (26) : 15788 - 15795
  • [42] Outcome of allogeneic hematopoietic stem cell transplantation in normal karyotype AML with NPM1 mutation in complete remission is not affected by FLT3/ITD positivity - potentially crucial importance of pre-transplant level of minimal residual disease
    Karas, M.
    Steinerova, K.
    Lysak, D.
    Hrabetova, M.
    Jungova, A.
    Pachner, M.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S475 - S475
  • [43] Effects of high doses of stem cell factor and FLT3-ligand on CD34+ cells from acute myeloid leukemia in first remission (CR1 AML)
    Herman, P
    Ferrant, A
    De Bruyére, M
    Straetmans, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 71 - 71
  • [44] Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells
    Nguyen, Chi Huu
    Grandits, Alexander M.
    Vassiliou, George S.
    Staber, Philipp B.
    Heller, Gerwin
    Wieser, Rotraud
    BIOMEDICINES, 2020, 8 (10)
  • [45] Novel Interactions between NFATc1 (Nuclear Factor of Activated T Cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) Mediate G Protein-coupled Receptor Agonist, Thrombin-induced Biphasic Expression of Cyclin D1, with First Phase Influencing Cell Migration and Second Phase Directing Cell Proliferation
    Kundumani-Sridharan, Venkatesh
    Dong Van Quyen
    Subramani, Jaganathan
    Singh, Nikhlesh K.
    Chin, Y. Eugene
    Rao, Gadiparthi N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (27) : 22463 - 22482
  • [46] AUTOCRINE INHIBITION BY TGF-BETA-1 SUPPRESSES FLT3 LIGAND (FLT3L) AND STEM-CELL FACTOR (SCF) STIMULATED GROWTH - EVIDENCE FOR TGF-BETA-1 GENE-EXPRESSION IN HEMATOPOIETIC-CELLS
    ZHU, XL
    NOVAK, FP
    HEINRICH, M
    OPPENLANDER, BK
    DOOLEY, DC
    BLOOD, 1994, 84 (10) : A221 - A221
  • [47] IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1)
    Chen, Zhihong
    Su, Lingkai
    Xu, Qingan
    Katz, Jenny
    Michalek, Suzanne M.
    Fan, Mingwen
    Feng, Xu
    Zhang, Ping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (50) : 30163 - 30174
  • [48] Secretion of a Truncated Osteopetrosis-associated Transmembrane Protein 1 (OSTM1) Mutant Inhibits Osteoclastogenesis through Down-regulation of the B Lymphocyte-induced Maturation Protein 1 (BLIMP1)-Nuclear Factor of Activated T Cells c1 (NFATc1) Axis
    Shin, Bongjin
    Yu, Jungeun
    Park, Eui-Soon
    Choi, Seunga
    Yu, Jiyeon
    Hwang, Jung Me
    Yun, Hyeongseok
    Chung, Young-Ho
    Hong, Kwan Soo
    Choi, Jong-Soon
    Takami, Masamichi
    Rho, Jaerang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (52) : 35868 - 35881
  • [49] Phase 3 study of quizartinib (AC220) monotherapy vs salvage chemotherapy (SC) in patients (pts) with FLT3-ITD+ acute myeloid leukemia (AML) refractory to or relapsed (R/R) after 1st-line treatment with or without hematopoietic stem cell transplant (HSCT) consolidation: the QuANTUM-R study
    Cortes, J.
    Gammon, G.
    Khaled, S.
    Martinelli, G.
    Kramer, A.
    Steffen, B.
    Hogge, D.
    Jonas, B. A.
    Dombret, H.
    Perl, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells
    Zhou, Yuning
    Wang, Qingding
    Guo, Zheng
    Weiss, Heidi L.
    Evers, B. Mark
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (15) : 2963 - 2972
12345